Reuters logo
BRIEF-Antisense Therapeutics FY loss $2.8 mln
August 29, 2017 / 8:09 AM / a month ago

BRIEF-Antisense Therapeutics FY loss $2.8 mln

Aug 29 (Reuters) - Antisense Therapeutics Ltd:

* FY revenue down 87.62 pct to $140,169

* FY net loss for period attributable $2.8 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below